Alaunos Therapeutics, Inc. Common Stock
TCRT
TCRT: Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens (neoAg) arising from genomic mutations.
moreShow TCRT Financials
Recent trades of TCRT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by TCRT's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on TCRT's company Twitter account
Number of mentions of TCRT in WallStreetBets Daily Discussion
Recent insights relating to TCRT
Recent picks made for TCRT stock on CNBC
ETFs with the largest estimated holdings in TCRT
Flights by private jets registered to TCRT